CapWealth Advisors LLC Buys 5,391 Shares of CVS Health Co. (NYSE:CVS)

CapWealth Advisors LLC lifted its position in CVS Health Co. (NYSE:CVS) by 1.6% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 337,977 shares of the pharmacy operator’s stock after buying an additional 5,391 shares during the quarter. CVS Health comprises approximately 1.7% of CapWealth Advisors LLC’s holdings, making the stock its 26th largest position. CapWealth Advisors LLC’s holdings in CVS Health were worth $15,172,000 at the end of the most recent reporting period.

Several other large investors have also modified their holdings of the company. MidAtlantic Capital Management Inc. bought a new stake in CVS Health during the third quarter valued at about $25,000. Livelsberger Financial Advisory acquired a new position in shares of CVS Health during the third quarter worth approximately $31,000. Legacy Investment Solutions LLC bought a new stake in CVS Health in the 3rd quarter valued at $31,000. Reston Wealth Management LLC acquired a new stake in CVS Health in the 3rd quarter worth $32,000. Finally, Ridgewood Investments LLC grew its position in CVS Health by 255.7% during the fourth quarter. Ridgewood Investments LLC now owns 626 shares of the pharmacy operator’s stock worth $28,000 after buying an additional 450 shares in the last quarter. 80.66% of the stock is owned by institutional investors.

CVS Health Stock Performance

CVS stock opened at $65.71 on Friday. CVS Health Co. has a twelve month low of $43.56 and a twelve month high of $80.75. The business’s fifty day moving average is $50.90 and its 200-day moving average is $56.01. The company has a quick ratio of 0.59, a current ratio of 0.80 and a debt-to-equity ratio of 0.80. The company has a market cap of $82.68 billion, a P/E ratio of 16.68, a price-to-earnings-growth ratio of 0.60 and a beta of 0.61.

CVS Health (NYSE:CVS) last issued its earnings results on Wednesday, February 12th. The pharmacy operator reported $1.19 EPS for the quarter, beating the consensus estimate of $0.89 by $0.30. CVS Health had a net margin of 1.36% and a return on equity of 10.72%. Equities research analysts forecast that CVS Health Co. will post 5.14 EPS for the current year.

CVS Health Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Monday, February 3rd. Stockholders of record on Thursday, January 23rd were issued a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a dividend yield of 4.05%. The ex-dividend date of this dividend was Thursday, January 23rd. CVS Health’s dividend payout ratio (DPR) is presently 67.51%.

Analyst Ratings Changes

A number of analysts have commented on CVS shares. Truist Financial raised their price objective on CVS Health from $60.00 to $76.00 and gave the stock a “buy” rating in a research report on Thursday. Leerink Partners raised shares of CVS Health from a “market perform” rating to an “outperform” rating and increased their price target for the stock from $55.00 to $75.00 in a research report on Thursday. Edward Jones upgraded CVS Health from a “hold” rating to a “buy” rating in a research report on Thursday, January 30th. UBS Group lowered their price target on CVS Health from $62.00 to $59.00 and set a “neutral” rating on the stock in a research report on Tuesday. Finally, Wells Fargo & Company increased their target price on shares of CVS Health from $68.00 to $73.00 and gave the stock an “overweight” rating in a research report on Thursday. Four analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $70.28.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.